HHS and ARPA-H Launch SURPASS Program to Accelerate Gene Therapy Trials with AI

HHS and ARPA-H have launched the SURPASS program, which uses artificial intelligence to accelerate and expand clinical trials — with potential to significantly shorten development timelines for gene therapies including CRISPR-based treatments. The initiative represents a major federal commitment to modernizing trial infrastructure and could benefit multiple ongoing gene therapy programs.